Precision Cancer Medicine: Large Studies Indicate Steady Progress | Zendy

Alexander M.M. Eggermont | Zendy; Birgit Geoerger | Zendy; Giuseppe Curigliano | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Precision Cancer Medicine: Large Studies Indicate Steady Progress

Author(s) -

Alexander M.M. Eggermont,

Birgit Geoerger,

Giuseppe Curigliano

Publication year - 2021

Publication title -

cancer discovery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.795

H-Index - 163

eISSN - 2159-8290

pISSN - 2159-8274

DOI - 10.1158/2159-8290.cd-21-1069

Subject(s) - precision medicine , cancer , cancer medicine , medicine , computational biology , bioinformatics , medical physics , biology , pathology

Summary: Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions provide the basis of precision cancer medicine. In this issue of Cancer Discovery, continued progress in this field is demonstrated by two large collaborative studies: Horak and colleagues in the MASTER trial for patients with rare cancers and Van Tilburg and colleagues in the INFORM registry in pediatric tumors. See related article by van Tilburg et al., p. 2764. See related article by Horak et al., p. 2780.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research